Home › Funds › Stonepine Capital Management, LLC › KZIA

Stonepine Capital Management, LLC position in KZIA

KAZIA THERAPEUTICS LTD · Health Care

Stonepine Capital Management, LLC reported holding 377,429 shares of KZIA (KAZIA THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 2.78% of its reported portfolio and ranking #11 among its reported holdings. Stonepine Capital Management, LLC has disclosed KZIA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)377.43K sh
Reported value held$3.62M
Portfolio Weight2.78%
First reportedQ4 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's KZIA position evolved

Stonepine Capital Management, LLC first disclosed a stake in KZIA in Q4 2025 at 460,359 shares (US$3.2M). The position peaked in Q2 2026 at 345,179 shares, worth US$4.9M. Across 4 filings, Stonepine Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 377,429 shares valued at US$3.6M — an increase of 32,250 shares quarter over quarter.. Notable position changes include a 25% trim in Q1 2026 (shares rose 89% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 460.36K $3.17M New
Q1 2026 345.18K $2.57M Reduce
Q2 2026 345.18K $4.86M Hold
Q3 2026 377.43K $3.62M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KZIA and 13F data

KZIA (KAZIA THERAPEUTICS LTD) is a Health Care company. 52 other funds we track also report a position in KZIA — the largest reported positions include Boxer Capital Management, LLC (US$7.9M), Ikarian Capital, LLC (US$5.6M), Dauntless Investment Group, LLC (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KZIA

All KZIA fund holders →

FAQ

How long has Stonepine Capital Management, LLC held KZIA?

Stonepine Capital Management, LLC has disclosed KZIA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Stonepine Capital Management, LLC's current position in KZIA?

As of Q3 2026, Stonepine Capital Management, LLC holds 377.43K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $3.62M, representing 2.78% of its reported portfolio and ranking #11.

Has Stonepine Capital Management, LLC been buying or selling KZIA?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in KZIA. The position peaked in Q2 2026 at 345.18K shares.

Which other funds hold KZIA?

Other major institutional holders of KZIA include Boxer Capital Management, LLC, Ikarian Capital, LLC, Dauntless Investment Group, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.